Evidence map›Paper›PMID 38001355›Full record

ArticleCommunications biology2023

p53 and p21 dynamics encode single-cell DNA damage levels, fine-tuning proliferation and shaping population heterogeneity.

Nica Gutu, Neha Binish, Ulrich Keilholz, Hanspeter Herzel, Adrián E Granada

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Nica GutuCharité Universitätsmedizin, Charité Comprehensive Cancer Center, Berlin, Germany.
Neha BinishCharité Universitätsmedizin, Charité Comprehensive Cancer Center, Berlin, Germany.ORCID 0009-0001-1508-8186
Ulrich KeilholzCharité Universitätsmedizin, Charité Comprehensive Cancer Center, Berlin, Germany.
Hanspeter HerzelCharité Universitätsmedizin, Charité Comprehensive Cancer Center, Berlin, Germany.ORCID 0000-0003-0414-7889
Adrián E GranadaCharité Universitätsmedizin, Charité Comprehensive Cancer Center, Berlin, Germany. adrian.granada@charite.de.ORCID 0000-0003-0537-9091
German Marine Research Consortium · DEHumboldt-Universität zu Berlin · DEHertie Institute for Clinical Brain Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells must accurately and quickly detect DNA damage through a set of checkpoint mechanisms that enable repair and control proliferation. Heterogeneous levels of cellular stress and noisy signaling processes can lead to phenotypic variability but little is known about their role in underlying proliferation heterogeneity. Here we study two previously published single cell datasets and find that cells encode heterogeneous levels of endogenous and exogenous DNA damage to shape proliferation heterogeneity at the population level. Using a comprehensive time series analysis of short- and long-term signaling dynamics of p53 and p21, we show that DNA damage levels are quantitatively translated into p53 and p21 signal parameters in a gradual manner. Analyzing instantaneous proliferation and signaling differences among equally-radiated cells, we identify time-localized changes in the period of p53 pulses that drive cells out of a low proliferative state. Our findings suggest a novel role of the p53-p21 network in quantitatively encoding DNA damage strength and fine-tuning proliferation trajectories.

Indexed as

DNA DamageTumor Suppressor Protein p53Cell ProliferationCyclin-Dependent Kinase Inhibitor p21HumansSignal TransductionCyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53

Identifiers

PMID38001355
PMCPMC10673849
OpenAlexW4388968122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.